Masaki Fujiwara, Yuto Yamada, Tsuyoshi Etoh, Taichi Shimazu, Masafumi Kodama, Norihito Yamada, Takahiro Asada, Shigeo Horii, Takafumi Kobayashi, Teruo Hayashi, et al. A feasibility study of provider-level implementation strategies to improve access to colorectal cancer screening for patients with schizophrenia: ACCESS2 (N-EQUITY 2104) trial. Implementation science communications. 2024. 5. 1. 2-2
Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, et al. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023
Shintaro Takenoshita, Seishi Terada, Tomokazu Inoue, Taku Kurozumi, Norihito Yamada, Ryozo Kuwano, Shigeru Suemitsu. Prevalence and modifiable risk factors for dementia in persons with intellectual disabilities. Alzheimer's research & therapy. 2023. 15. 1. 125-125
Tomonari Hosokawa, Chikara Miyaji, Yusaku Yoshimura, Kenji Washida, Yuji Yada, Shinji Sakamoto, Yuko Okahisa, Soshi Takao, Akira Nomura, Yoshiki Kishi, et al. Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting. Psychopharmacology. 2023
Yuto Yamada, Masaki Fujiwara, Tsuyoshi Etoh, Riho Wada, Shinichiro Inoue, Yoshiko Mimaki, Masafumi Kodama, Yusaku Yoshimura, Shigeo Horii, Takanori Matsushita, et al. Perceptions toward issues in cancer care for people with mental illness among psychiatric care providers: A questionnaire study. Psycho-oncology. 2023. 32. 7. 1022-1029
